Literature DB >> 19289502

Spi-1 and Fli-1 directly activate common target genes involved in ribosome biogenesis in Friend erythroleukemic cells.

Gaëtan Juban1, Guillaume Giraud, Boris Guyot, Stéphane Belin, Jean-Jacques Diaz, Joëlle Starck, Christel Guillouf, Françoise Moreau-Gachelin, François Morlé.   

Abstract

Spi-1 and Fli-1 are ETS transcription factors recurrently deregulated in mouse erythroleukemia induced by Friend viruses. Since they share the same core DNA binding site, we investigated whether they may contribute to erythroleukemia by common mechanisms. Using inducible knockdown, we demonstrated that Fli-1 contributes to proliferation, survival, and differentiation arrest of erythroleukemic cells harboring an activated fli-1 locus. Similarly, we used inducible Fli-1 knockdown and either hexamethylenebisacetamide (HMBA)- or small interfering RNA-mediated Spi-1 knockdown to investigate their respective contributions in erythroleukemic cells harboring an activated spi-1 locus. In these cells, simple or double knockdown of both Spi-1 and Fli-1 additively contributed to induce proliferation arrest and differentiation. Transcriptome profiling revealed that virtually all transcripts affected by both Fli-1 knockdown and HMBA are affected in an additive manner. Among these additively downregulated transcripts, more than 20% encode proteins involved in ribosome biogenesis, and conserved ETS binding sites are present in their gene promoters. Through chromatin immunoprecipitation, we demonstrated the association of Spi-1 and Fli-1 on these promoters in Friend erythroleukemic cells. These data lead us to propose that the oncogenicity of Spi-1, Fli-1, and possibly other ETS transcription factors may involve their ability to stimulate ribosome biogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289502      PMCID: PMC2682047          DOI: 10.1128/MCB.01435-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

1.  MDM2 suppresses p73 function without promoting p73 degradation.

Authors:  X Zeng; L Chen; C A Jost; R Maya; D Keller; X Wang; W G Kaelin; M Oren; J Chen; H Lu
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.

Authors:  C T Quang; O Wessely; M Pironin; H Beug; J Ghysdael
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

3.  FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.

Authors:  R Pereira; C T Quang; I Lesault; H Dolznig; H Beug; J Ghysdael
Journal:  Oncogene       Date:  1999-02-25       Impact factor: 9.867

4.  Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells.

Authors:  T Yamada; N Kondoh; M Matsumoto; M Yoshida; A Maekawa; T Oikawa
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

5.  Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells.

Authors:  Giuseppina M Carbone; Sara Napoli; Alessandra Valentini; Franco Cavalli; Dennis K Watson; Carlo V Catapano
Journal:  Nucleic Acids Res       Date:  2004-08-16       Impact factor: 16.971

6.  Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition.

Authors:  Mu-Shui Dai; Shelya X Zeng; Yetao Jin; Xiao-Xin Sun; Larry David; Hua Lu
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

7.  Production of erythropoietin by cloned malignant murine erythroid cells.

Authors:  J Choppin; N Casadevall; C Lacombe; F Wendling; E Goldwasser; R Berger; P Tambourin; B Varet
Journal:  Exp Hematol       Date:  1985-08       Impact factor: 3.084

8.  Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.

Authors:  J Starck; A Doubeikovski; S Sarrazin; C Gonnet; G Rao; A Skoultchi; J Godet; I Dusanter-Fourt; F Morle
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

9.  Induction of murine erythroleukemia differentiation by actinomycin D.

Authors:  M Terada; E Epner; U Nudel; J Salmon; E Fibach; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

10.  Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.

Authors:  S Barnache; F Wendling; C Lacombe; N Denis; M Titeux; W Vainchenker; F Moreau-Gachelin
Journal:  Oncogene       Date:  1998-06-11       Impact factor: 9.867

View more
  11 in total

1.  Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells.

Authors:  Xiongwei Cai; Long Gao; Li Teng; Jingping Ge; Zaw Min Oo; Ashish R Kumar; D Gary Gilliland; Philip J Mason; Kai Tan; Nancy A Speck
Journal:  Cell Stem Cell       Date:  2015-07-09       Impact factor: 24.633

2.  Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1.

Authors:  Adrian Mehlitz; Sebastian Banhart; André P Mäurer; Alexis Kaushansky; Andrew G Gordus; Julia Zielecki; Gavin Macbeath; Thomas F Meyer
Journal:  J Cell Biol       Date:  2010-07-12       Impact factor: 10.539

3.  Spi-1, Fli-1 and Fli-3 (miR-17-92) oncogenes contribute to a single oncogenic network controlling cell proliferation in friend erythroleukemia.

Authors:  Samer Kayali; Guillaume Giraud; François Morlé; Boris Guyot
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

4.  Drug-mediated inhibition of Fli-1 for the treatment of leukemia.

Authors:  Y-J Li; X Zhao; L M Vecchiarelli-Federico; Y Li; A Datti; Y Cheng; Y Ben-David
Journal:  Blood Cancer J       Date:  2012-01-27       Impact factor: 11.037

5.  NLS-tagging: an alternative strategy to tag nuclear proteins.

Authors:  Guillaume Giraud; Ralph Stadhouders; Andrea Conidi; Dick H W Dekkers; Danny Huylebroeck; Jeroen A A Demmers; Eric Soler; Frank G Grosveld
Journal:  Nucleic Acids Res       Date:  2014-09-26       Impact factor: 16.971

Review 6.  The ets transcription factor Fli-1 in development, cancer and disease.

Authors:  Y Li; H Luo; T Liu; E Zacksenhaus; Y Ben-David
Journal:  Oncogene       Date:  2014-06-09       Impact factor: 9.867

7.  Fli-1 overexpression in erythroleukemic cells promotes erythroid de-differentiation while Spi-1/PU.1 exerts the opposite effect.

Authors:  Laura M Vecchiarelli-Federico; Tangjingjun Liu; Yao Yao; Yuanyuan Gao; Yanmei Li; You-Jun Li; Yaacov Ben-David
Journal:  Int J Oncol       Date:  2017-06-02       Impact factor: 5.650

8.  Friend virus limits adaptive cellular immune responses by imprinting a maturation-resistant and T helper type 2-biased immunophenotype in dendritic cells.

Authors:  Limei Shen; Stefan Tenzer; Moritz Hess; Ute Distler; Ingrid Tubbe; Evelyn Montermann; Simone Schimmer; Ulf Dittmer; Stephan Grabbe; Matthias Bros
Journal:  PLoS One       Date:  2018-02-09       Impact factor: 3.240

9.  Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathway.

Authors:  Ota Fuchs
Journal:  Leuk Res Treatment       Date:  2012-02-13

10.  GATA1 and PU.1 Bind to Ribosomal Protein Genes in Erythroid Cells: Implications for Ribosomopathies.

Authors:  Elsa P Amanatiadou; Giorgio L Papadopoulos; John Strouboulis; Ioannis S Vizirianakis
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.